All mutants except for 3J113v2 were also capable of strongly inhibiting the infection of pseudotyped SARS-CoV-1, another ACE2-dependent coronavirus, indicating wide-range of therapeutic potential of 3N39v2 and 3J320v2 mutants (Fig. 1c, Supplementary Fig. 7b). This evidence concerns the gene ACE2 and infection.